Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wikler

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Bioethics|July 1, 1997
Presidential address: bioethics and social responsibilityDaniel Wikler
Bioethics|April 1, 1993
Brain death: a durable consensus?Daniel Wikler
Cost Effectiveness and Resource Allocation : C/E|May 30, 2003
Why prioritize when there isn't enough money?Daniel Wikler
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|February 1, 1994
Federal bioethics: methodology, expertise, and evaluationDaniel Wikler
Bioethics|October 22, 2020
Bystanders and ethical review of research: Proceed with cautionDaniel Wikler
Ethics & International Affairs|February 16, 2005
Personal and social responsibility for healthDaniel Wikler
Journal of Medical Ethics|August 31, 2016
Must research benefit human subjects if it is to be permissible?Daniel Wikler
The American Journal of Bioethics : AJOB|July 22, 2014
Brain dead patients are still whole organismsNicholas Sadovnikoff, Daniel Wikler
Clinical Trials (London, England)|August 2, 2019
Ethical complexities of responding to bystander risk in HIV prevention trialsNir Eyal, Daniel Wikler
The Hastings Center Report|August 1, 1981
A rationale for fetal viabilityDavid Pomeranz, Daniel Wikler
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Bioethics|July 1, 1997
Presidential address: bioethics and social responsibilityDaniel Wikler
Bioethics|April 1, 1993
Brain death: a durable consensus?Daniel Wikler
Cost Effectiveness and Resource Allocation : C/E|May 30, 2003
Why prioritize when there isn't enough money?Daniel Wikler
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|February 1, 1994
Federal bioethics: methodology, expertise, and evaluationDaniel Wikler
Bioethics|October 22, 2020
Bystanders and ethical review of research: Proceed with cautionDaniel Wikler
Ethics & International Affairs|February 16, 2005
Personal and social responsibility for healthDaniel Wikler
Journal of Medical Ethics|August 31, 2016
Must research benefit human subjects if it is to be permissible?Daniel Wikler
The American Journal of Bioethics : AJOB|July 22, 2014
Brain dead patients are still whole organismsNicholas Sadovnikoff, Daniel Wikler
Clinical Trials (London, England)|August 2, 2019
Ethical complexities of responding to bystander risk in HIV prevention trialsNir Eyal, Daniel Wikler
The Hastings Center Report|August 1, 1981
A rationale for fetal viabilityDavid Pomeranz, Daniel Wikler
Pageof 3